iNtRON Confirms Efficacy of CDL200 Against CDI Clinical Isolates

/PRNewswire/ -- iNtRON Biotechnology ("iNtRON", www.intodeworld.com) announced today that CDL200, a novel biological drug candidate under the development of...

Related Keywords

Burlington ,Massachusetts ,United States ,Seoul ,Soult Ukpyolsi ,South Korea ,Seongnam ,Kyonggi Do ,Sagimakgol ,Boston ,Delaware ,Sang Hyeon ,Gyeonggi Do ,Republic Of Korea , ,Ntron Biotechnology Inc ,Intodeworld Inc ,Bd Team ,Tae Kyu Tk Bd Team Leader ,Kyung Won ,Inflammatory Bowel Disease ,Vice President ,Tae Kyu ,Intron Biotechnology ,Nc ,